David Angulo's most recent trade in Scynexis Inc was a trade of 23,000 Common Stock done at an average price of $0.8 . Disclosure was reported to the exchange on April 9, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Scynexis Inc | David Angulo | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.84 per share. | 09 Apr 2025 | 23,000 | 816,598 (0%) | 0% | 0.8 | 19,320 | Common Stock |
| Scynexis Inc | David Angulo | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 1.05 per share. | 19 Mar 2025 | 13,800 | 793,598 (0%) | 0% | 1.1 | 14,490 | Common Stock |
| Scynexis Inc | David Angulo | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 1.07 per share. | 19 Mar 2025 | 5,000 | 779,798 (0%) | 0% | 1.1 | 5,350 | Common Stock |
| Scynexis Inc | David Angulo | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 394,391 | 394,391 | - | - | Employee Stock Option (Right to Buy) | |
| Scynexis Inc | David Angulo | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 262,927 | 770,798 (0%) | 0% | 0 | Common Stock | |
| Scynexis Inc | David Angulo | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.37 per share. | 12 Sep 2024 | 20,000 | 507,871 (0%) | 0% | 1.4 | 27,400 | Common Stock |
| Scynexis Inc | David Angulo | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2024 | 431,030 | 431,030 | - | - | Employee Stock Option (Right to Buy) | |
| Scynexis Inc | David Angulo | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2024 | 290,590 | 479,871 (0%) | 0% | 0 | Common Stock | |
| Scynexis Inc | David Angulo | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2023 | 165,000 | 165,000 | - | - | Employee Stock Option (Right to Buy) | |
| Scynexis Inc | David Angulo | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2023 | 110,000 | 185,181 (0%) | 0% | 0 | Common Stock | |
| Scynexis Inc | David Angulo | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 85,000 | 85,000 | - | - | Stock Option (Right to Buy) | |
| Scynexis Inc | David Angulo | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 51,100 | 74,981 (0%) | 0% | 0 | Common Stock | |
| Scynexis Inc | David Angulo | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2021 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Scynexis Inc | David Angulo | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 6.25 per share. | 21 Dec 2020 | 1,600 | 23,780 (0%) | 0% | 6.3 | 10,000 | Common Stock |
| Scynexis Inc | David Angulo | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2020 | 800 | 800 | - | - | Common Stock Warrant | |
| Scynexis Inc | David Angulo | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2020 | 800 | 800 | - | - | Common Stock Warrant |